Skip to main content
. 2018 Nov 27;37(3):391–405. doi: 10.1007/s40273-018-0745-z

Fig. 2.

Fig. 2

KM plots and parametric distributions for PFS, OS and TTD. Left: gBRCAmut (a PFS; b OS; c TTD). Right: non-gBRCAmut (d PFS; e OS; f TTD). KM Kaplan–Meier, OS overall survival, PFS progression-free survival, RS routine surveillance, TTD time to treatment discontinuation